The Incidence of Febrile Neutropenia in the First Course of Adjuvant Chemotherapy with Docetaxel/Cyclophosphamide with or without Pegfilgrastim.

被引：0
|
作者：
Jones, S. [1 ]
Paul, D. [1 ]
Sedlacek, S. [1 ]
Vukelja, S. [1 ]
Wilks, S. T. [1 ]
Stokoe, C. [1 ]
Osborne, C. R. [1 ]
Krekow, L. [1 ]
McIntyre, K. [1 ]
Holmes, F. A. [1 ]
Guerra, L. [1 ]
Zhan, F. [1 ]
Asmar, L. [1 ]
O'Shaughnessy, J. [1 ]
Blum, J. L. [1 ]
机构：
[1] US Oncol, The Woodlands, TX USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/0008-5472.SABCS11-P5-18-09
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-18-09
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Incidence of febrile neutropenia with adjuvant docetaxel and cyclophosphamide in patients with early breast cancer
    Marinho, F. D. S.
    Lopes, M. D. S. D. S.
    Monteiro, M. M. F.
    Gifoni, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Febrile neutropenia with adjuvant docetaxel and cyclophosphamide (TC) chemotherapy for breast cancer.
    Yu, Joanne Linda
    Kurin, Michael
    Pasetka, Mark
    Sridhar, Srikala S.
    Warner, Ellen
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Febrile neutropenia in adjuvant docetaxel and cyclophosphamide (TC) with prophylactic pegfilgrastim in patients with breast cancer: A retrospective analysis
    Ngamphaiboon, N.
    Advani, P. P.
    O'Connor, T. L.
    Ademuyiwa, F. O.
    Levine, E. G.
    Riebandt, G.
    Kossoff, E. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] Febrile neutropenia in adjuvant docetaxel and cyclophosphamide (TC) with prophylactic pegfilgrastim in breast cancer patients: a retrospective analysis
    Ngamphaiboon, Nuttapong
    O'Connor, Tracey L.
    Advani, Pooja P.
    Levine, Ellis G.
    Kossoff, Ellen B.
    MEDICAL ONCOLOGY, 2012, 29 (03) : 1495 - 1501
  • [5] Febrile neutropenia in adjuvant docetaxel and cyclophosphamide (TC) with prophylactic pegfilgrastim in breast cancer patients: a retrospective analysis
    Nuttapong Ngamphaiboon
    Tracey L. O’Connor
    Pooja P. Advani
    Ellis G. Levine
    Ellen B. Kossoff
    Medical Oncology, 2012, 29 : 1495 - 1501
  • [6] High incidence of febrile neutropenia seen following adjuvant chemotherapy with docetaxel plus cyclophosphamide for early breast cancer
    Gilbar, Peter
    McPherson, Ian
    Sorour, Natacha
    Sanmugarajah, Jasotha
    Francesconi, Alessandra
    McCaffrey, Elizabeth
    BREAST CANCER MANAGEMENT, 2014, 3 (01) : 9 - 11
  • [7] Incidence of Febrile Neutropenia in Patients Treated with Docetaxel and Cyclophosphamide (TC) for Adjuvant Breast Cancer
    Yee, J.
    Chan, J.
    Fehrenbacher, L.
    Fredriks, D.
    Chen, D.
    Wong, W.
    Colley, D.
    CANCER RESEARCH, 2011, 71
  • [8] Primary prophylaxis of febrile neutropenia during adjuvant docetaxel and cyclophosphamide (TC) chemotherapy for breast cancer
    Yu, J. L.
    Kurin, M.
    Pasetka, M.
    Kiss, A.
    Chan, K.
    Sridhar, S. S.
    Warner, E.
    CANCER RESEARCH, 2013, 73
  • [9] High incidence of febrile neutropenia following adjuvant breast chemotherapy with docetaxel, carboplatin and trastuzumab
    Gilbar, Peter
    McPherson, Ian
    Sorour, Natacha
    Sanmugarajah, Jasotha
    BREAST CANCER MANAGEMENT, 2014, 3 (04) : 327 - 333
  • [10] Clinical impact of febrile neutropenia (FIN) increase among patients receiving adjuvant docetaxel/cyclophosphamide (TC) chemotherapy compared to TC plus pegfilgrastim for breast cancer
    Hamilton, Erika Paige
    Topping, Donna L.
    Peppercorn, Jeffrey M.
    Marcom, P. Kelly
    Kimmick, Gretchen Genevieve
    Duff, Erin
    Cirrincione, Constance T.
    Blackwell, Kimberly L.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345